Introducing new Vineti PTM^® flexibility features: next-gen label printing and rescheduling innovations deliver critical workflow options that advanced therapies require...

For Vineti, 2020 has been all about continuing to deliver progress for advanced therapies, even amid an unpredictable year. One...

Today, we’re very excited and honored to announce the extension of our Series C round of funding. We’ve expanded the...

Next week marks the start of a very important annual event in advanced therapies — the Alliance for Regenerative Medicine’s...

“Crispr — overrated or underrated?” At this month’s CBInsights Future of Health conference, I had the good fortune to do a live...

Proven biotech/pharma executive and advanced therapies pioneer Joe DePinto brings extensive commercial expertise to the industrialization of cell and gene...

Today, Vineti is thrilled to announce that Joe DePinto has joined us as our Chief Commercial Officer. Joe is a long-time leader in...

Vineti Inc. named to the 2020 CB Insights Digital Health 150 — List of Most Innovative Digital Health StartupsVineti Inc....

Avobis Bio and Vineti announce strategic collaboration to support new implantable cell therapies addressing debilitating conditions NEWARK, Del. and SAN...

Integrated Commercial Services and Personalized Therapy Management systems to seamlessly track product and patient journey SAN FRANCISCO, Calif. and CHICAGO,...

Today, I’m really excited to share more progress from Vineti. We’ve launched the new Vineti Alliance Network to deliver an enterprise-grade approach...

Our company was founded in 2016 to bring life to the following vision: “Vineti works to create a world where individualized,...